Home
Browse
Search
Statistics
About
Usage
PMID: 24593045
Marson FA, Bertuzzo CS, Ribeiro AF, Ribeiro JD
Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study.
BMC Med Genet. 2014 Mar 4;15:27. doi: 10.1186/1471-2350-15-27.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
47
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24593045:47:189
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 24593045:47:182
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 24593045:47:200
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24593045:47:167
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24593045:47:174
status:
NEW
view ABCC7 p.Arg1162* details
CFTR mutation identification CFTR mutation identification was performed by polymerase chain reaction (PCR) for F508del and the fragment-length polymorphism method for
G542X
,
R1162X
,
R553X
,
G551D
, and
N1303K
mutations.
Login to comment
48
ABCC7 p.Ile618Thr
X
ABCC7 p.Ile618Thr 24593045:48:149
status:
NEW
view ABCC7 p.Ile618Thr details
Some CF mutations were identified by sequencing or Multiplex Ligation-dependent Probe Amplification (MLPA) analysis: S4X, 2183A > G, 1717-G > A, and
I618T
.
Login to comment
51
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 24593045:51:72
status:
NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Pro205Ser
X
ABCC7 p.Pro205Ser 24593045:51:62
status:
NEW
view ABCC7 p.Pro205Ser details
All class I, II or III mutations, but not class IV mutations (
P205S
and
R334W
), identified were included in statistical analysis.
Login to comment
121
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 24593045:121:609
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 24593045:121:586
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24593045:121:540
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24593045:121:671
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24593045:121:692
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24593045:121:712
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24593045:121:778
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24593045:121:563
status:
NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24593045:121:677
status:
NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24593045:121:736
status:
NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24593045:121:743
status:
NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24593045:121:794
status:
NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ile618Thr
X
ABCC7 p.Ile618Thr 24593045:121:698
status:
NEW
view ABCC7 p.Ile618Thr details
An analysis of genotypic combinations for GSTM1 and GSTP1 polymorphic loci showed that changes in GSTP1 activities Table 3 Genotyping of GCLC, GSTM1, GSTT1, and GSTP1 polymorphisms and CFTR mutations Gene Chromosomal position Location Polymorphism MAF HWE p-valuea GCLC, rs17883901 6p12 Promoter region C > T 0.12 9.97 <0.005 GCLC, rs137852340 6p12 Promoter region A > G 0.19 0.04 >0.05 GSTP1, rs1695 11q13 Exon A > G 0.25 1.11 >0.05 GSTM1 1p13.3 Deletion GSTT1 22q11.23 Deletion CFTR mutation N Frequency F508del/F508del 57 31.67% F508del/
G542X
12 6.67% F508del/
R1162X
5 2.78% F508del/
N1303K
4 2.22% F508del/
R553X
1 0.56% F508del/S4X 1 0.56% F508del/1717-1G > A 1 0.56%
G542X
/
R1162X
1 0.56%
G542X
/
I618T
1 0.56%
G542X
/2183A > G 1 0.56%
R1162X
/
R1162X
1 0.56% F508del/- 45 25.00%
G542X
/- 5 2.78%
R1162X
/- 1 0.56% -/- 44 24.45% MAF, Minor allele frequency; HWE, Hardy Weinberg Equilibrium; a P-value for Hardy-Weinberg Equilibrium; N, Number of patients; -, No identified CFTR mutation.
Login to comment